These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26055147)
1. Differential uptake of recent Papanicolaou testing by HPV vaccination status among young women in the United States, 2008-2013. Sauer AG; Jemal A; Simard EP; Fedewa SA Cancer Epidemiol; 2015 Aug; 39(4):650-5. PubMed ID: 26055147 [TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient. Guo F; Hirth JM; Berenson AB J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084 [TBL] [Abstract][Full Text] [Related]
3. Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine. Higgins LM; Dirksing KN; Ding L; Morrow CD; Widdice LA; Kahn JA Hum Vaccin Immunother; 2016 Jun; 12(6):1498-503. PubMed ID: 26934107 [TBL] [Abstract][Full Text] [Related]
4. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination. Malo TL; Perkins RB; Lee JH; Vadaparampil ST Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046 [TBL] [Abstract][Full Text] [Related]
5. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States. Johnson NL; Head KJ; Scott SF; Zimet GD Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053 [TBL] [Abstract][Full Text] [Related]
6. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results. Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631 [TBL] [Abstract][Full Text] [Related]
7. Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System. Chodick G; Leader AE; Larson S Cancer Prev Res (Phila); 2021 Apr; 14(4):415-420. PubMed ID: 33687944 [TBL] [Abstract][Full Text] [Related]
8. Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study. Greaney ML; Cohen SA; Allen JD BMC Public Health; 2024 Jul; 24(1):1954. PubMed ID: 39039466 [TBL] [Abstract][Full Text] [Related]
9. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance. Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831 [TBL] [Abstract][Full Text] [Related]
10. Risk Behaviors Correlate with Higher Prevalence of Papanicolaou, Human Papillomavirus, and Human Immunodeficiency Virus Screening Among Women in the United States. Merrill RM; Williams EN; Fuhriman H J Womens Health (Larchmt); 2021 Apr; 30(4):615-624. PubMed ID: 33085563 [No Abstract] [Full Text] [Related]
11. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia. Touch S; Oh JK BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466 [TBL] [Abstract][Full Text] [Related]
12. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey. Watson M; Benard V; King J; Crawford A; Saraiya M Prev Med; 2017 Jul; 100():243-247. PubMed ID: 28502575 [TBL] [Abstract][Full Text] [Related]
13. Use of cervical cancer preventive services among US women aged 21-29: an assessment of the 2010 Affordable Care Act rollout through 2018. Garrido CO; Coşkun RA; Lent AB; Calhoun E; Harris RB Cancer Causes Control; 2020 Sep; 31(9):839-850. PubMed ID: 32602058 [TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening among young adult women in the United States. Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601 [TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152 [TBL] [Abstract][Full Text] [Related]
17. Assessing the Relationship Between Motherhood and Cervical Cancer Screening and Prevention Behaviors. Ginocchi A; Rogan EM; Conley CC J Womens Health (Larchmt); 2023 Apr; 32(4):494-502. PubMed ID: 36827467 [No Abstract] [Full Text] [Related]
18. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society. Ilter E; Celik A; Haliloglu B; Unlugedik E; Midi A; Gunduz T; Ozekici U Int J Gynecol Cancer; 2010 Aug; 20(6):1058-62. PubMed ID: 20683417 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751 [TBL] [Abstract][Full Text] [Related]
20. Sexual Orientation Differences in Cervical Cancer Prevention among a Cohort of U.S. Women. Solazzo AL; Agénor M; Austin SB; Chavarro JE; Charlton BM Womens Health Issues; 2020; 30(4):306-312. PubMed ID: 32249004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]